Periodontal Therapeutics Global Market By Product, Assumptions, Analysis and Forecasts to 2023
ReportsWeb.com published “Periodontal Therapeutics Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, October 12, 2017 ) According to Publisher, the Global Periodontal Therapeutics Market is valued at $259.34 million in 2016 and is expected to reach $511.76 million by 2023 growing at a CAGR of 10.2% from 2016 to 2023. Owing to increasing pool of diabetic patients will raise the Periodontal Therapeutics market growth. In addition, rising prevalence of periodontal disorders and the surging research activities for technological advancements in therapeutics are some factors positively impacting the growth. On the other hand, lack of favourable reimbursement policies in various countries across the world may limit the growth of this market.
By product, systemic antibiotics segment have the largest market share and is expected to remain the same for next few years due to high market penetration by product affordability. Followed by local antibiotics segment expected to grow faster due less chances of formation of resistant bacteria following fewer side effects. North American region has the largest market share in periodontal therapeutics market by increasing healthcare expenditure leading to increased demand for better oral healthcare therapeutics. Asia Pacific region is expected to grow at a higher CAGR during the forecast period owing to its population growth.
For more information @ http://www.reportsweb.com/periodontal-therapeutics-global-market-outlook-2017-2023
Some of the key players in the market include Fibrocell Sciences, Inc, Tolmar Inc, Eli Lilly & Company, Align Technology Inc., Dentsply International, 3M-ESPE, Ultradent Products Inc., Nobel Biocare Holdings AG, Glidewell Laboratories, Inc., Orapharma, Kaken Pharmaceutical, Valeant Pharmaceuticals Int. Inc, Den-Mat Holdings, Mallinckrodt Pharmaceuticals, Purdue Pharma L.P., Teva Pharmaceutical Industries Limited .
Product Type Covered:
-Local Antibiotics
-Arestin
-Other Local Antibiotics
- Systemic Antibiotics
-Minocycline
-Metronidazole
-Doxycycline
-Other Systemic Antibiotics
Distribution Channel Covered:
-Retail Pharmacies
-E-Commerce
-Drug Stores
-Hospitals Pharmacies
Request Sample Copy http://www.reportsweb.com/inquiry&RW00011033076/sample
Regions Covered:
-North America
-US
-Canada
-Mexico
-Europe
-Germany
-U.K
-France
-Italy
-Spain
-Rest of Europe
-Asia Pacific
-Japan
-China
-India
-Australia
-New Zealand
-South Korea
-Rest of Asia Pacific
-South America
-Argentina
-Brazil
-Chile
-Rest of South America
-Middle East & Africa
-Saudi Arabia
-UAE
-Qatar
-South Africa
Make an enquiry: http://www.reportsweb.com/inquiry&RW00011033076/buying
By product, systemic antibiotics segment have the largest market share and is expected to remain the same for next few years due to high market penetration by product affordability. Followed by local antibiotics segment expected to grow faster due less chances of formation of resistant bacteria following fewer side effects. North American region has the largest market share in periodontal therapeutics market by increasing healthcare expenditure leading to increased demand for better oral healthcare therapeutics. Asia Pacific region is expected to grow at a higher CAGR during the forecast period owing to its population growth.
For more information @ http://www.reportsweb.com/periodontal-therapeutics-global-market-outlook-2017-2023
Some of the key players in the market include Fibrocell Sciences, Inc, Tolmar Inc, Eli Lilly & Company, Align Technology Inc., Dentsply International, 3M-ESPE, Ultradent Products Inc., Nobel Biocare Holdings AG, Glidewell Laboratories, Inc., Orapharma, Kaken Pharmaceutical, Valeant Pharmaceuticals Int. Inc, Den-Mat Holdings, Mallinckrodt Pharmaceuticals, Purdue Pharma L.P., Teva Pharmaceutical Industries Limited .
Product Type Covered:
-Local Antibiotics
-Arestin
-Other Local Antibiotics
- Systemic Antibiotics
-Minocycline
-Metronidazole
-Doxycycline
-Other Systemic Antibiotics
Distribution Channel Covered:
-Retail Pharmacies
-E-Commerce
-Drug Stores
-Hospitals Pharmacies
Request Sample Copy http://www.reportsweb.com/inquiry&RW00011033076/sample
Regions Covered:
-North America
-US
-Canada
-Mexico
-Europe
-Germany
-U.K
-France
-Italy
-Spain
-Rest of Europe
-Asia Pacific
-Japan
-China
-India
-Australia
-New Zealand
-South Korea
-Rest of Asia Pacific
-South America
-Argentina
-Brazil
-Chile
-Rest of South America
-Middle East & Africa
-Saudi Arabia
-UAE
-Qatar
-South Africa
Make an enquiry: http://www.reportsweb.com/inquiry&RW00011033076/buying
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results